BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24533058)

  • 1. Essential medicines are more available than other medicines around the globe.
    Bazargani YT; Ewen M; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
    PLoS One; 2014; 9(2):e87576. PubMed ID: 24533058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
    Todesco B; Ostuzzi G; Barbui C
    Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
    Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
    BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries.
    Cameron A; Roubos I; Ewen M; Mantel-Teeuwisse AK; Leufkens HG; Laing RO
    Bull World Health Organ; 2011 Jun; 89(6):412-21. PubMed ID: 21673857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.
    Kasonde L; Tordrup D; Naheed A; Zeng W; Ahmed S; Babar ZU
    BMC Health Serv Res; 2019 Jun; 19(1):383. PubMed ID: 31196078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
    Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
    Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability, prices and affordability of selected essential medicines in Jordan: a national survey.
    Alefan Q; Amairi R; Tawalbeh S
    BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
    Bertoldi AD; Helfer AP; Camargo AL; Tavares NU; Kanavos P
    Global Health; 2012 Mar; 8():6. PubMed ID: 22436555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prices & availability of common medicines at six sites in India using a standard methodology.
    Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
    Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability, prices and affordability of essential medicines in Zhejiang Province, China.
    Dong Z; Tao Q; Yan B; Sun G
    PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
    Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
    Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
    Kotwani A
    BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What essential medicines for children are on the shelf?
    Robertson J; Forte G; Trapsida JM; Hill S
    Bull World Health Organ; 2009 Mar; 87(3):231-7. PubMed ID: 19377720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
    Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV
    BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.